$EKNL – On Xtreme Alert for Key Major Updates, ready to

New Post Public Reply Private Reply Replies (0) Message Board

Oct 30, 2012 at 9:12 AM

$EKNL – On Xtreme Alert for Key Major Updates, ready to rocket towards $2+

Markets will be closed again today due to Hurricane Sandy, but we will be going full steam with EKNL showing its HUGE potential for Mega Gains. In fact, we will continue to profile EKNL well into November.

EKNL’s buzz is getting real crazy and is primed for a MAJOR breakout when Markets open on Wednesday. Be sure to stay tuned for MAJOR updates to be unleashed by the company and MONSTER contracts coming out from the 13th annual medical conference last weekend

EKNL is definitely shaping up to be the BEST play of 2012.

EKNL soared to another all time high on Friday and hitting an all time high price of $0.775.

Technicals are screaming a MAJOR BULLISH BREAKOUT with a confirmed long term GOLDEN CROSS already established.

We have seen how golden crosses can breakout prices big time, in fact our other monster medical company Lifevantage (LFVN), which interesting enough announced a share buy back as well as recently uplisted to Nasdaq soared big time when a golden cross hit.

What makes LFVN and EKNL monster plays are from key similarities.

1) No dilution or insiders selling any time soon and especially at these super low prices. In fact, this leads to our second key similarity,

“Upon the achievement of a positive income statement and the repayment of its liabilities, the Company intends to initiate a program to buy-back common shares on the open market.”

2) Share buyback in effect. Definitely the goal here is to move prices up to proper valuations and big boards like Nasdaq requirements. We also got confirmation with recent announcement selecting MaloneBailey LLP, Certified Public Accounting Firm for appointment as auditors of the Company.

3) Super Low float. With only 5.5 Million active float (shares available at the DTC for trading), EKNL‘s share inventory is drying up super fast, and this is already triggering a MAJOR BULLISH BREAKOUT.

LFVN traded only pennies like EKNL and soared to over $3 per share shortly after their golden cross formation shown below.

Investors can definitely see the same pattern here with EKNL and is following in the exact same path as NASDAQ listed Lifevantage (L$VN)

You bet, there will be many more eyes on this play and also institutional groups now eying our near term price target of $2.00 per share. The potential here is insane with more than triple gains at current levels in the cards

Of course what really stands EKNL apart from everyone else is the relationships and key connections it has build so far.

EKNL released monster news announcing EKO’s Dr. Ziemer of NeuroVasc Medical Inc. and NCI, distributor of Neurometrix (NASDAQ:NURO)’s NC-Stat DPN check device are now available in 100 of WalMart-Canada stores.”

Perry Mayer BSc, MB, Bch, BAO, CCFPDr. Paul Ziemer, world renowned for his expertise in the medical field joined the team at EKNL.

EKNL launched first of many Clinics starting to treat patients with their FDA approved FREMS technology that was also presented at the 13th annual Medical this weekend!

Also, Dr. Ziemer teamed up with Dr. Snow of Neurometrix, a NASDAQ Listed company (NURO) for exclusive hands on demonstration of their testing unit at the show.

No doubt, these are MONSTER updates that are turning a lot of heads, and institutional investors now eying that multi-dollar target level.

These updates already give EKNL HUGE valuation and potential…

…BUT, IT IS WHAT’S STILL TO BE UNLEASHED BY EKNL THAT WILL NOT ONLY BE MIND ‘BLOWING’ IT WILL PROPEL EKNL PRICES ’SKY HIGH’ AND INTO RECORD TERRITORY

With an active float of only 5.5 Million shares and insiders not selling a single share, share inventory continues to dry up super quick making EKNL prices to move fast and furious towards higher levels.

Eko International Cp (EKNL) Stock Research Links

EKNL Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MetroScape: Local Roots Fuel Bold DFW Growth Plans

A Local Business with Big Aspirations Here's the deal, folks: Local guys Dr. Marc Nickell and Chris Brewer snatched up MetroScape Landscape like it was the last slice of grandma's pie. Why? Not just for the greenbacks—they're putting down roots in their very own backyard, the Dallas-Fort Worth area. What Does Local Really Mean? Look, it's one thing hitting up a...

Ozelle's O-Cyte 1: Revolutionizing Hematology with AI

O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...

UPM Defies Market Challenges: Strong Q3 Cash Flow

UPM's Impressive Q3 Performance Amidst Challenges UPM-Kymmene Corporation just dropped their Q3 numbers, and let me tell ya, there's a lot to digest. In the face of some pretty gnarly market conditions—think destocking and those pesky cost inflations—they've managed to pull a rabbit out of the hat with strong cash flow. That's not a small feat, folks; it's a damn...

2021 Ferrari Portofino Shines Bright at Jake's Motorcars

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Greek-Serbian Heads Meet to Prep for 2027 Tourism Expo

Breaking Cultural and Business Barriers You ever get that feeling when two neighbors finally decide to have a proper sit-down and hash things out? That's the vibe in Athens today, as Greek and Serbian movers and shakers are gathering to lay the groundwork for EXPO 2027 Belgrade. It's a match that's kinda hard to ignore if you're watching Europe's trade routes—especially...

Royce Micro-Cap Trust: Navigating Small-Cap Waves

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

Ryde Group Faces Class Action: Key Investor Takeaways

Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...

White House Photographer Reveals Unseen Historic Moments

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Ad Council Expands Board, Taps Meta Exec as Vice Chair

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Medunik USA Ensures Steady Supply of Pheburane Amid Changes

There's a breath of relief in the air over at Medunik USA, where they're keeping a steady course amidst some choppy waters. Those dealing with urea cycle disorders (UCD) have had their fair share of ups and downs, but Pheburane® isn’t going anywhere anytime soon. Medunik USA Holds the Line So, picture yourself in the shoes of a patient battling a rare urea cycle...